Loading clinical trials...
Loading clinical trials...
End-Stage Liver Disease (ESLD) is one of the ten leading causes of death in US. It is marked by episodic acute exacerbations of the underlying liver disease which often leads to severe symptoms, poor ...
Bring this clarity to your next appointment.
Keep all your medical notes and next steps in one place.
Lead Sponsor
Albert Einstein Healthcare Network
NCT06455280 · Autoimmune Liver Disease, Liver Transplant Disorder, and more
NCT03803423 · End Stage Renal Disease, End Stage Liver Disease
NCT06136221 · Cirrhosis, Liver, End Stage Liver DIsease, and more
NCT02581085 · End Stage Liver Disease, NASH - Nonalcoholic Steatohepatitis, and more
NCT05253287 · Liver Cirrhosis, Fibrosis, and more
Einstein Healthcare Network
Philadelphia, Pennsylvania
Use Clareo to keep notes, questions, trial details, and next steps organized before and after appointments.
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions